Sulfated polysaccharides as multi target molecules to fight COVID 19 and comorbidities

Enrique Javier Carvajal-Barriga; R. Douglas Fields

doi:10.1016/j.heliyon.2023.e13797

Sulfated polysaccharides as multi target molecules to fight COVID 19 and comorbidities

Enrique Javier Carvajal-Barriga
, R. Douglas Fields^*

^*Autor correspondiente de este trabajo

Facultad de Ciencias Exactas, Naturales y Ambientales

Producción científica: Revista › Artículo › revisión exhaustiva

15 Citas (Scopus)

Idioma original	Inglés
Publicación	Heliyon
Volumen	9
N.º	3
DOI	https://doi.org/10.1016/j.heliyon.2023.e13797
Estado	Publicada - 17 feb. 2023

Nota bibliográfica

Publisher Copyright:
© 2023

Financiación

Financiadores	Número del financiador
National Institute of Child Health and Human Development	ZIAHD000713

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1016/j.heliyon.2023.e13797

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{a24bdf554c7e4220b7899453a6e7fdc7,

title = "Sulfated polysaccharides as multi target molecules to fight COVID 19 and comorbidities",

keywords = "Anti-bacterial, Antioxidant, Antiviral saccharides, COVID-19 and comorbidities, Cancer, Diabetes, Heparin, Hypertension, Immunomodulation, Multi-target drugs, Viral infection",

author = "Carvajal-Barriga, \{Enrique Javier\} and Fields, \{R. Douglas\}",

note = "Publisher Copyright: {\textcopyright} 2023",

year = "2023",

month = feb,

day = "17",

doi = "10.1016/j.heliyon.2023.e13797",

language = "English",

volume = "9",

journal = "Heliyon",

issn = "2405-8440",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Sulfated polysaccharides as multi target molecules to fight COVID 19 and comorbidities

AU - Carvajal-Barriga, Enrique Javier

AU - Fields, R. Douglas

PY - 2023/2/17

Y1 - 2023/2/17

KW - Anti-bacterial

KW - Antioxidant

KW - Antiviral saccharides

KW - COVID-19 and comorbidities

KW - Cancer

KW - Diabetes

KW - Heparin

KW - Hypertension

KW - Immunomodulation

KW - Multi-target drugs

KW - Viral infection

UR - https://www.scopus.com/pages/publications/85149807728

U2 - 10.1016/j.heliyon.2023.e13797

DO - 10.1016/j.heliyon.2023.e13797

M3 - Article

SN - 2405-8440

VL - 9

JO - Heliyon

JF - Heliyon

IS - 3

ER -